Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis.
Levels of soluble IL-2 receptors, IL-6, soluble CD23, soluble CD14 and ECP (eosinophilic cationic protein) were measured as markers of T-cell, B-cell, monocyte and eosinophilic leucocyte activation in 26 patients with atopic dermatitis (AD) on admission to (A) and at discharge from (D) the Department of Dermatology in Zurich. The serum levels of sIL-2R, IL-6, sCD23, sCD14 and ECP were significantly elevated in AD patients in comparison with the normal values of healthy donors. A significant decrease in sIL-2R (p = 0.0093) and in sCD14 (p = 0.0134) levels was demonstrated between A and D, correlating with the improvement in the skin intensity score (SIS). In addition, a significant correlation of the sCD14 levels and the SIS at A was demonstrated (p = 0.0415). These results also incriminate monocytes in the pathogenesis of AD, indicating that, besides sIL-2R and ECP, SCD14 could also be a possible marker for the disease activity.
Wüthrich
B
B
Department of Dermatology, University Hospital, Zurich, Switzerland.
Kägi
M K
MK
Joller-Jemelka
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000032:analysis*; D015214:Antigens, Differentiation, Myelomonocytic / Q000032:analysis*; D001798:Blood Proteins / Q000032:analysis; D003876:Dermatitis, Atopic / Q000276:immunology*; D047091:Eosinophil Granule Proteins; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000032:analysis*; D018950:Lipopolysaccharide Receptors; D008297:Male; D008875:Middle Aged; D012260:Ribonucleases
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D015850:Interleukin-6; D018950:Lipopolysaccharide Receptors; D012260:Ribonucleases